Neostigmine interactions with non steroidal anti-inflammatory drugs

British Journal of Pharmacology

Volumn 135, Issue 7, 2002, Pages 1591-1597

  Miranda, Hugo F ^a   Sierralta, Fernando ^a   Pinardi, Gianni ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Antinociception; Isobolographic analysis; Neostigmine; NSAIDs; Writhing test

Indexed keywords

ACETYLCHOLINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; DICLOFENAC; KETOPROFEN; MELOXICAM; NEOSTIGMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; INTERNEURON; MOUSE; NONHUMAN; PAIN; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; WRITHING TEST;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHOLINESTERASE INHIBITORS; DICLOFENAC; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; KETOPROFEN; MICE; NEOSTIGMINE; PAIN; PAIN MEASUREMENT; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; THIAZINES; THIAZOLES;

EID: 0036965551     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704599     Document Type: Article

References (38)

1. ABRAM, S.E. & WINNE, R.P. (1995). Intrathecal acetyl cholinesterase inhibitors produce analgesia that is synergistic with morphine and clonidine in rats. Anesth. Analg., 81, 501-507.
2. BARTOLINI, A., GHELARDINI, C., FANTETTI, L., MALCANGIO, M., MALMBERG-AIELLO, P. & GIOTTI, A. (1992). Role of muscarinic receptor subtypes in central antinociception. Br. J. Pharmacol., 105, 77-82.
3. BERNARDINI, N., SAUER, S.K., HABERBERGER, R., FISCHER, M.J. & REEH, P.W. (2001). Excitatory nicotinic and desensitizing muscarinic (M2) effects on C-nociceptors in isolated rat skin. J. Neurosci., 21, 3295-3302.
4. BOUAZIZ, H., HEWITT, C. & EISENACH, J.C. (1995). Subarachnoid neostigmine potentiation of alpha 2-adrenergic agonist analgesia. Dexmedetomidine versus clonidine. Reg. Anesth., 20, 121-127.
5. BUERKLE, H., BOSCHIN, M., MARCUS, M.A., BRODNER, G., WUSTEN, R. & VAN ANKEN, H. (1998). Central and peripheral analgesia mediated by acetylcholinesterase-inhibitor neostigmine in the rat inflamed knee joint model. Anesth. Analg., 86, 1027-1032.
6. CHIARI, A., TOBIN, J.R., PAN, H.L., HOOD, D.D. & EISENACH, J.C. (1999). Sex differences in cholinergic analgesia. I: a supplemental nicotinic mechanism in normal females. Anesthesiology, 91, 1447-1454.
7. CRYER, B. & FELDMAN, N (1998). Cyclo-oxygenase-1 and cyclo-oxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am. J. Med., 104, 413-421.
8. EISENACH, J.C. (1999). Muscarinic-mediated analgesia. Life Sci., 64, 549-554.
9. EISENACH, J.C. & GEBHART, G.F. (1995). Intrathecal amitryptiline. Antinociceptive interactions with intravenous morphine and intrathecal clonidine, neostigmine and carbamylcholine in rats. Anesthesiology, 83, 1036-1045.
10. GHELARDINI, C., FANTETTI, L., MALCANGIO, M., MALMBERG-AIELLO, P., GIOTTI, A. & BARTOLINI, A. (1990). Methoctramine increases cholinergic neurotransmission by acting presynaptically, Pharmacol. Res., 22, 227.
11. GILLBERG, P.G., GORDH, JR. T, HARTVIG, O., JANSSON, I., PETTERSSON, J. & POST, C. (1989). Characterization of the antinociception induced by intrathecally administered carbachol. Pharmacol. Toxicol., 64, 340-343.
12. GUIMARAES, A.P. & PRADO, W.A. (1994). Antinociceptive effects of carbachol microinjected into different portions of the mesencephalic periaqueductal gray matter of the rat. Brain Res., 674, 220-230.
13. HARTVIG, P., GILLBERG, P.G., GORDH, JR. T. & POST, C. (1989). Cholinergic mechanisms in pain and analgesia. Trends Pharmacol. Sci., (Suppl.): 75-79.
14. HOOD, D.K., MALLAK, K.A., JAMES, R.L., TUTTLE, R. & EISENACH, J.C. (1997). Enhancement of analgesia from systemic opioid in humans by spinal cholinesterase inhibition. J. Pharmacol. Exp. Ther., 282, 86-92.
15. HYLDEN, J.L.K. & WILCOX, G.L. (1980). Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol., 67, 313-316.
16. IWAMOTO, E.T. & MARION, L. (1993). Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats. J. Pharmacol. Exp. Ther., 266, 329-338.
17. MALMBERG, A.B. & YAKSH, T.L. (1993). Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology, 79, 270-281.
18. MARNETT, L.J. & KALGUTKAR, A.S. (1999). Cyclooxygenase 2 inhibitors: discovery, selectivity and the future. Trends. Pharmacol. Sci., 20, 465-469.
19. MIRANDA, H.F., SIERRALTA, F. & PINARDI, G. (2001). An isobolographic analysis of the adrenergic modulation of diclofenac antinociception. Anesth. Analg., 93, 430-435.
20. MITCHELL, J.A. & WARNER, T.D. (1999). Cyclo-oxygenase2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Brit. J. Pharmacol., 128, 1121-1132.
21. NAGUIB, M. & YAKSH, T.L. (1997). Characterization of muscarinic receptor subtypes that mediates antinociception in the rat spinal cord. Anesth. Analg., 85, 847-853.
22. NUSEIR, K., HEIDENRICH, B.A. & PROUDFIT, H.K. (1999). The antinociception produced by microinjection of a cholinergic agonist in the ventromedial medulla is mediated by noradrenergic nurons in the A7 catecholamines cell group. Brain Res., 822, 1-7.
23. OSSIPOV, M.H., HARRIS, S., LLOYD, P. & MESSINEO, E. (1990). An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opioids. J. Pharmacol. Exp. Ther., 255, 1107-1116.
24. PAIK, J.H., JU, J.H., LEE, J.Y., BOUDRAEU, M.D. & HWANG, D.H. (2000). Two opposing effects of non steroidal anti-inflammatory drugs on the expression of the inducible cyclooxygenase. Mediation through different signaling pathways. J. Biol. Chem., 275, 28173-28179.
25. PINARDI, G., PELISSIER, T., MIRANDA, H.F. (1998). Interactions in the antinociceptive effect of tramadol in mice: an isobolographic analysis. Enz. J. Pain., 2, 343-350
26. PINARDI, G., SIERRALTA, F. & MIRANDA, H.F. (2001). Interaction between the antinociceptive effect of ketoprofen and adrenergic modulatory systems. Inflammation, 25, 233-239.
27. ROERIG, S.C., FUJIMOTO, J.M. & TSENG, L.F. (1988). Comparisons of descending pain inhibitory pathways activated by β-endorphin and morphine as characterized by supraspinal and spinal antinociceptive interactions in mice. J. Pharmacol. Exp. Ther., 247, 1107-1113.
28. ROERIG, S.C., O'BRIEN, S., FUJIMOTO, J.M. & WILCOX, G.L. (1984). Tolerance to morphine analgesia: Decreased multiplicative interaction between spinal and supraspinal sites. Brain Res., 308, 360-363.
29. SMITH, A.L., DEWITT, D.L. & GARAVITO, R.M. (2000). Cyclooxygenases: structural, cellular, and molecular biology. Ann. Rev. Biochem., 69, 145-182.
30. SOLOMON, R.E. & GEBHART, G.F. (1994). Synergistic antinociceptive interactions among drugs administered to the spinal cord. Anesth. Analg., 78, 1164-1172.
31. TALLARIDA, R.J. (2001). Drug synergism: its detection and applications. J. Pharmacol. Exp. Ther., 298, 865-872.
32. TALLARIDA, R.J., PORRECA, F. & COWAN, A. (1989). Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci., 45, 947-961.
33. VANE, J.R., BAKHLE, Y.S. & BOTTING, R.M. (1998). Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol., 38, 97-120.
34. WARNER, T.D., GIULIANO, F., VOJNOVIC, I., BUKASA, A., MITCHELE J.A. & VANE, J.R. (1999). Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc. Natl. Acad. Sci. U.S.A., 96, 7563-7568.
35. YANG, L.C., CHEN, L.M., WANG, C.J. & BUERKLE, H. (1998). Postoperative analgesia by intra-articular neostigmine in patients undergoing knee arthroscopy. Anesthesiology, 88, 334-339.
36. YEUNG, J.C. & RUDY, T.A. (1980). Multiplicative interactions between narcotic agonism expressed at spinal and supraspinal sites of action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine. J. Pharmacol. Exp. Ther., 215, 633-642.
37. SUH, H.H. & TSENG, L.F. (1988). Intrathecal beta-funaltrexine antagonizes intracerebroventricular beta-endorphin but not morphine-induced analgesia in mice. J. Pharmacol. Exp. Ther., 245, 587-593.
38. XU, Z., LI, P., TONG, C., FIGUEROA, J., TOBIN, J.R. & EISENACH, J.C. (1996). Location and characteristics of nitro oxide synthase in sheep spinal cord and its interaction with alpha(2)-adrenergic and cholinergic antinociception. Anesthesiology, 84, 890-899.